Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 190
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05581121 | PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer | ||
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer | ||
| NCT03875820 | Phase I Trial of Defactinib and VS-6766. | ||
| NCT03592550 | The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver | ||
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | ||
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | ||
| NCT04509986 | GlobalSurg-CovidSurg Week | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT03673787 | A Trial of Ipatasertib in Combination With Atezolizumab | ||
| NCT00107497 | Radiation Therapy in Treating Women With Localized Breast Cancer | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT02338622 | Trial of Olaparib in Combination With AZD5363 (ComPAKT) | ||
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT01337401 | A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) | ||
| NCT03466944 | PUMA (Paediatric Osseous Marrow Assessment) | ||
| NCT07372885 | GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia | ||
| NCT07432932 | Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients | ||
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study | ||
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer | ||
| NCT01964677 | MR-HIFU for Bone Metastases | ||
| NCT05810467 | The Active Surveillance Study | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT02389842 | PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | ||
| NCT07498829 | Population Based Germline Testing for Early Detection and Prevention of Cancer | ||
| NCT03262311 | Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours | ||
| NCT03857477 | The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. | ||
| NCT02380027 | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | ||
| NCT02193633 | A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. | ||
| NCT02714621 | MR-HIFU for Recurrent Gynaecological Cancer | ||
| NCT03256981 | Stereotactic Body Radiotherapy for the Treatment of OPD | ||
| NCT00692354 | Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | ||
| NCT01000129 | Adaptive Planning in Bladder Cancer | ||
| NCT00199901 | Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma | ||
| NCT07008742 | Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer | ||
| NCT02170415 | Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery | ||
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | ||
| NCT00392535 | Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT01726374 | Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours | ||
| NCT00499174 | Observation or Radical Treatment in Patients With Prostate Cancer | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | ||
| NCT01476462 | Second Malignant Neoplasms After Childhood ALL Therapy | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT02757651 | KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response |
